l9n/ Mississippi

2026 Regular Session

House Bill 1667

Prescription drugs; require that value of manufacturer copay assistance be applied to reduce patient deductible/out-of-pocket maximum costs.

Did not become law. It stopped in the House of Representatives's State Affairs Committee on February 3, 2026.

What it does

The synopsis the Legislature published with the bill.

AN ACT TO REQUIRE THAT HEALTH BENEFIT PLANS AND PRESCRIPTION DRUG PROGRAMS THAT PROVIDE COVERAGE FOR PRESCRIPTION DRUGS AND RECEIVE MANUFACTURER COPAY ASSISTANCE FOR A PRESCRIPTION DRUG MUST APPLY THE VALUE OF THE COPAY ASSISTANCE TO REDUCE OR LIMIT THE AMOUNT THAT A PATIENT PAYS FOR A PRESCRIPTION DRUG AND/OR APPLY THE VALUE OF SUCH ASSISTANCE TO A PATIENT'S ANNUAL COST-SHARING REQUIREMENTS, SUCH AS DEDUCTIBLES AND OUT-OF-POCKET MAXIMUM COSTS; TO BRING FORWARD SECTIONS 83-9-5 AND 83-9-6.1, MISSISSIPPI CODE OF 1972, WHICH RELATE TO ACCIDENT AND HEALTH INSURANCE, FOR THE PURPOSES OF POSSIBLE AMENDMENT; AND FOR RELATED PURPOSES.

Sponsors

Who carried the bill in each chamber, and who signed on. Each name leads to the member's page.

In the House of Representatives

Its course

January 19 to February 3, 2026, on one scale. In the top row each mark is a day something happened; taller marks are busier days.

Each committee stop sits inside its chamber.

Every action2 actions on 2 days

In the House of RepresentativesJan 19 to Feb 3 · stopped15 days

State AffairsJan 19 to Feb 3 · stopped15 days

Text

Each version as the Legislature printed it.

l9n doesn't hold this bill's text yet.

What happened

In l9n's words, one line for each step. Every action as the Legislature published it is below.

In the House of Representatives Jan 19 – Feb 3

  1. Referred to the House committee on State Affairs
  2. Died in committee in the House
All 2 actions, as published